Bottom line
How much do IHE and FHLC overlap?
41% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 57.6% of IHE's assets and 30.9% of FHLC's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 59), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IHE and FHLC have in common
| Holding | % of IHE | % of FHLC | Overlap |
|---|---|---|---|
| Johnson & Johnson | 22.44% | 8.93% | 8.93% |
| Eli Lilly And Company | 22.25% | 13.35% | 13.35% |
| Merck & Co., Inc. | 4.55% | 4.66% | 4.55% |
| Bristol-myers Squibb Company | 4.37% | 1.93% | 1.93% |
| Pfizer Inc. | 3.96% | 2.06% | 2.06% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IHE
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
- Royalty Pharma Plc — 4.34%
- Viatris Inc. — 4.22%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
- Elanco Animal Health Incorporated — 2.81%
- Axsome Therapeutics, Inc. — 2.42%
- Corcept Therapeutics Incorporated — 1.90%
- Ligand Pharmaceuticals Incorporated — 1.45%
- Definium Therapeutics Inc — 1.39%
- Liquidia Corp — 1.28%
- Indivior Pharmaceuticals, Inc. — 1.14%
- Crinetics Pharmaceuticals Inc — 0.90%
- Organon & Co. — 0.81%
- Edgewise Therapeutics Inc — 0.70%
Only in FHLC
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- CVS Health Corp — 1.92%
- Intuitive Surgical Inc — 1.82%
- Danaher Corp — 1.80%
- Vertex Pharmaceuticals Inc — 1.76%
- Stryker Corp — 1.62%
- Medtronic PLC — 1.59%
- McKesson Corp — 1.52%
- Elevance Health Inc — 1.19%
- Regeneron Pharmaceuticals Inc — 1.15%
Asset mix
| Asset type | IHE | FHLC |
|---|---|---|
| Stocks | 99.9% | 99.7% |
| Cash & short-term funds | 6.3% | 0.2% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | IHE | FHLC |
|---|---|---|
| US | 96.4% | 96.5% |
| GB | 4.3% | 0.5% |
| IE | 3.8% | 2.2% |
| CA | 1.4% | 0.2% |
| BM | — | 0.2% |
| SG | 0.2% | — |
| KY | 0.2% | — |
| CH | — | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do IHE and FHLC overlap?
What stocks do IHE and FHLC have in common?
Should I own both IHE and FHLC?
Which holds more stocks, IHE or FHLC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.